Timothy M. Mayleben, President & CEO at Esperion Therapeutics, Inc. (ESPR), bought 10,000 shares at $36.98 ($370K) on 2019-11-06, disclosed to the SEC on 2019-11-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.98 | 5,000 | $185K | 50.0% |
| 2 | $36.98 | 5,000 | $185K | 50.0% |
| Total | $36.98 avg | 10,000 | $370K | 100% |
| Filing → |
| ESPR | BUY | 2019-09-06 | $259K | — | Filing → |
| ESPR | BUY | 2019-08-02 | $198K | — | Filing → |
| ESPR | BUY | 2019-07-01 | $230K | — | Filing → |